The index patient was a Canadian family physician aged 54 years with
a history of hyperlipidemia, hypertension, and noninsulin-dependent diabetes
controlled on oral medications. During April 1-2, 2003, he examined three
patients who were family members involved in a community cluster of SARS in
Toronto, Ontario.2 No infection-control
precautions were used. On April 4, he had fever, myalgia, headache, mild diarrhea,
and a dry cough; on medical evaluation, he had a clear chest radiograph, but
he continued to feel ill during home isolation. On April 8, he was reevaluated
and found to have a left upper-lobe infiltrate on a repeat chest radiograph;
he was admitted to the SARS ward of hospital A. During the next several days,
he remained febrile with increasing cough, although his diarrhea resolved.
On April 12, the patient's temperature was 104.7°F (40.4°C), his chest
radiograph showed worsening pneumonia, and he required supplemental oxygen
for hypoxia. He was treated with ipratropium bromide and albuterol sulfate
by metered dose inhaler, intravenous (IV) ribavirin, and steroids. On April
12, he had a nearly constant cough and was assessed for transfer to the intensive
care unit (ICU). On April 13, the patient was transported to the ICU in a
wheelchair on 100% oxygen through nonrebreather face mask. Soon after his
arrival in the ICU, his measured oxygen saturation decreased to 60%, and he
was placed on positive pressure ventilation through face mask (BiPAP). Because
of severe cough and agitation, he removed the mask repeatedly despite administration
of IV sedation. After an approximately 2-hour attempt to provide oxygen through
BiPAP, the patient was intubated. During intubation, he had copious frothy
secretions that later obstructed the ventilator tubing, requiring disconnection
and drainage. Once supported with mechanical ventilation, the patient was
sedated further by using IV midazolam/morphine sulfate.